Ashburton (Jersey)’s Novartis NVS Stock Holding History

Ashburton (Jersey)’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-608	Closed	-$57K	–	69
2020 Q4	$57K	Hold	608	–	–	0.03%	39
2020 Q3	$53K	Hold	608	–	–	0.03%	38
2020 Q2	$53K	Hold	608	–	–	0.03%	38
2020 Q1	$50K	Hold	608	–	–	0.02%	51
2019 Q4	$58K	Hold	608	–	–	0.02%	54
2019 Q3	$53K	Hold	608	–	–	0.03%	62
2019 Q2	$56K	Sell	608 -71	-10%	-$6.01K	0.03%	62
2019 Q1	$51K	Hold	679	–	–	0.03%	43
2018 Q4	$52K	Hold	679	–	–	0.02%	55
2018 Q3	$52K	Buy	+679	New	+$50.2K	0.02%	67

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ashburton (Jersey)'s NVS Position: Q1 2021 in Review

Ashburton (Jersey) sold out of Novartis (NVS) in Q1 2021, closing a stake of 608 shares — an estimated $57K sold.

Ashburton (Jersey) first reported a position in NVS in Q3 2018 and held it in 10 quarters. The position peaked at $58K in Q4 2019. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

Ashburton (Jersey) reported no remaining Novartis position as of Q1 2021 after selling out during the quarter.
Ashburton (Jersey) sold 608 Novartis shares in Q1 2021, an estimated $57K.
Ashburton (Jersey) first reported a position in Novartis in Q3 2018 and held it in 10 quarters.
Ashburton (Jersey)'s Novartis position peaked at $58K in Q4 2019.
1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on Ashburton (Jersey)'s 13F filing for Q1 2021, filed 26 May 2023.